Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Juvenile Idiopathic Arthritis (sJIA)”

41 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41 results

Not applicableLooking for participantsNCT05925452
What this trial is testing

To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis.

Who this might be right for
Active Systemic Juvenile Idiopathic Arthritis
Changchun GeneScience Pharmaceutical Co., Ltd. 221
Large-scale testing (Phase 3)Study completedNCT02396212
What this trial is testing

Study of Efficacy and Safety of Canakinumab in Japanese Patients With SJIA

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Novartis Pharmaceuticals 19
Large-scale testing (Phase 3)Study completedNCT00144612
What this trial is testing

Long-term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Chugai Pharmaceutical 60
Large-scale testing (Phase 3)Study completedNCT00889863
What this trial is testing

Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis With Active Flare
Novartis Pharmaceuticals 177
Large-scale testing (Phase 3)Study completedNCT00277251
What this trial is testing

Alendronate Osteoporosis Study

Who this might be right for
Glucocorticoid-Associated Osteopenia and Osteoporosis
Boston Children's Hospital 20
Large-scale testing (Phase 3)Study completedNCT00339157
What this trial is testing

Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS

Who this might be right for
Systemic-Onset Juvenile Idiopathic Arthritis
Institut National de la Santé Et de la Recherche Médicale, France 24
Large-scale testing (Phase 3)Looking for participantsNCT05609630
What this trial is testing

Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.

Who this might be right for
Juvenile Idiopathic Arthritis
AbbVie 90
Large-scale testing (Phase 3)Study completedNCT05001737
What this trial is testing

Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE

Who this might be right for
Macrophage Activation SyndromeSecondary Hemophagocytic LymphohistiocytosisStill Disease+4 more
Swedish Orphan Biovitrum 33
Early research (Phase 1)UnknownNCT05027373
What this trial is testing

Safety, Tolerability and Pharmacokinetic of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection

Who this might be right for
Systemic Juvenile Idiopathic ArthritisPeriodic Fever Syndrome
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 34
Large-scale testing (Phase 3)Study completedNCT00144664
What this trial is testing

Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Chugai Pharmaceutical 19
Not applicableStudy completedNCT03932344
What this trial is testing

Long-term Safety Study of Kineret® in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)

Who this might be right for
Still Disease, Juvenile Onset
Swedish Orphan Biovitrum 306
Not applicableLooking for participantsNCT03510442
What this trial is testing

Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related Conditions

Who this might be right for
Still's Disease, Adult-OnsetSystemic InflammationArthritis+1 more
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 2,000
Early research (Phase 1)Study completedNCT01803321
What this trial is testing

Study to Evaluate the Safety and Tolerability of Two Doses of Rilonacept in Pediatric Subjects With Active Systemic Juvenile Idiopathic Arthritis (SJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Regeneron Pharmaceuticals 24
Not applicableNot Yet RecruitingNCT06718049
What this trial is testing

Role of Interleukin 18 (IL-18) and Interleukin 18 Binding Protein (IL-18BP) in the Diagnostic Work-up of Systemic Juvenile Idiopathic Arthritis and Autoinflammatory Diseases: Possible Biomarkers in the Differential Diagnosis of Other Febrile Diseases

Who this might be right for
Systemic Juvenile Idiopathic Arthritis (sJIA)
IRCCS Azienda Ospedaliero-Universitaria di Bologna 9
Large-scale testing (Phase 3)WithdrawnNCT01676948
What this trial is testing

An Open-label, Multi-arm, Non-comparative Safety and Tolerability Study of Canakinumab (ACZ885) in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00534495
What this trial is testing

Safety and Effectiveness of Rilonacept for Treating Systemic Juvenile Idiopathic Arthritis in Children and Young Adults

Who this might be right for
Juvenile Idiopathic Arthritis
Montefiore Medical Center 71
Large-scale testing (Phase 3)Study completedNCT03000439
What this trial is testing

A Safety, Efficacy And Pharmacokinetics Study Of Tofacitinib In Pediatric Patients With sJIA

Who this might be right for
Arthritis Juvenile Idiopathic
Pfizer 100
Not applicableLooking for participantsNCT06838143
What this trial is testing

Ilaris NIS in Korea

Who this might be right for
Hereditary Periodic Fever SyndromesCryopyrin-associated Periodic Syndromes (CAPS)Colchicine Resistance Familial Mediterranean Fever (crFMF)+3 more
Novartis Pharmaceuticals 25
Testing effectiveness (Phase 2)Study completedNCT00426218
What this trial is testing

Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)

Who this might be right for
Arthritis, Juvenile Rheumatoid
Novartis 26
Large-scale testing (Phase 3)Study completedNCT00642460
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Patients With Active Systemic Juvenile Idiopathic Arthritis (JIA)

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 112
Load More Results